Research graph
References from All-cause mortality in statin-associated immune-mediated necrotizing myopathy compared with idiopathic inflammatory myopathy. Local targets link to admitted publications; unresolved targets remain external evidence.
Inflammatory muscle diseases
10.1056/nejmc1506827 · 2015 · External reference
Classification and management of adult inflammatory myopathies
10.1016/s1474-4422(18)30254-0 · 2018 · External reference
International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland). 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
10.1136/annrheumdis-2017-211468 · 2017 · External reference
Recent updates on the pathogenesis of inflammatory myopathies
10.1007/s11926-024-01164-7 · 2024 · External reference
Statin-associated autoimmune myopathy
10.1056/nejmra1515161 · 2016 · External reference
Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy
10.1002/art.30156 · 2011 · External reference
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study
10.1016/j.autrev.2016.07.023 · 2016 · External reference
A novel autoantibody recognizing 200-kDa and 100-kDa proteins is associated with an immune-mediated necrotizing myopathy
10.1002/art.27572 · 2010 · External reference
Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin
10.1097/md.0000000000000028 · 2014 · External reference
Anti-HMGCR myopathy: clinical and histopathological features, and prognosis
10.1097/bor.0000000000000832 · 2021 · External reference
Immune-mediated necrotizing myopathy associated with statins: history and recent developments
10.1097/bor.0000000000000438 · 2017 · External reference
Clinical features and treatment outcomes of necrotizing autoimmune myopathy
10.1001/jamaneurol.2015.1207 · 2015 · External reference
224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands
10.1016/j.nmd.2017.09.016 · 2018 · External reference
Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy
10.1136/bcr-2022-248880 · 2022 · External reference
Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota
10.1002/mus.27504 · 2022 · External reference
Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features
10.1097/01.md.0000109755.65914.5e · 2004 · External reference
Long-term survival of patients with idiopathic inflammatory myopathies: anatomy of a single-centre cohort
10.55563/clinexprheumatol/486yh4 · 2023 · External reference
Impact of dysphagia and its severity on long-term survival and swallowing function outcomes in patients with idiopathic inflammatory myopathies other than inclusion body myositis
10.1111/1756-185x.14365 · 2022 · External reference
Survival of patients with idiopathic inflammatory myopathies in Slovenia
10.3389/fmed.2021.801078 · 2021 · External reference
Increased prevalence and incidence of statin-associated IMNM in Native Americans
10.1093/rheumatology/keaf618 · 2025 · External reference
Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies
10.1093/rheumatology/keaa337 · 2021 · External reference
Statin-associated immune-mediated necrotizing myositis in Native Americans
10.1093/rheumatology/keac198 · 2022 · External reference
Increased risk of statin-associated autoimmune myopathy among American Indians
10.1002/art.42126 · 2022 · External reference
Outcomes in 45 patients with statin-associated myopathy
10.1001/archinte.165.22.2671 · 2005 · External reference
Statin-induced rhabdomyolysis: a comprehensive review of case reports
10.3138/ptc.2012-65 · 2014 · External reference
Statin-induced necrotizing autoimmune myopathy: a systematic review
10.5114/reum.2022.114108 · 2022 · External reference
Benefits of early versus late initiation of intravenous immunoglobulin in the treatment of patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase immune-mediated necrotizing myopathy
10.1002/acr.25406 · 2024 · External reference
Unresolved reference
External reference
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index
10.1002/art.24904 · 2009 · External reference
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography
10.1016/j.echo.2010.05.010 · 2010 · External reference
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases
10.1002/art.42860 · 2024 · External reference
An introduction to propensity score methods for reducing the effects of confounding in observational studies
10.1080/00273171.2011.568786 · 2011 · External reference
Using big data to emulate a target trial when a randomized trial is not available
10.1093/aje/kwv254 · 2016 · External reference
Treatment of immune-mediated necrotizing myopathy
10.1007/s40674-023-00210-2 · 2023 · External reference
Immune-mediated necrotizing myopathy: a systematic review of antibody-specific mechanisms and treatment outcomes
10.7759/cureus.97933 · 2025 · External reference
Adverse effects of corticosteroids on the cardiovascular system
2000 · External reference
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy
10.1093/rheumatology/kew470 · 2017 · External reference
